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WHAT IS THE FAMILY HEALTH HISTORY?

• Health record of a patient and his/ her relatives
• Includes the information of three generation of relatives
including: children, brothers/ sisters, parents, aunts/ uncles,
nieces/ nephews, grandparents and cousins
• Helps the healthcare provider assess a patient’s risk for
hereditary cancers and diseases

“

“AN ACCURATE FAMILY HISTORY IS A WE LLE STAB LISHE D ME THOD TO RE COGNIZE
GE NE TIC DISORDE RS AND SUSCE PTIB ILITIE S
THAT MAY POSE RISK S FOR FUTURE HE ALTH
PROB LE MS. IT RE MAINS ONE OF THE MOST
POWE RFUL “GE NE TIC TE STS” TO IDE NTIFY
INDIVIDUALS AT RISK FOR INHE RITAB LE
DISORDE RS”

AMERICAN MEDICAL ASSOCIATION, 2004

American Medical Association, 20041

”

WHY COLLECT THE FHH?

• Empower the patient and the healthcare provider
• Identify a patient at risk then:
• patient can be proactive in managing their health

• healthcare provider has guidance and evidence on recommendations for further
testing/ screening

THE PROBLEM IN COLLECTION OF THE
FHH: UNDERUTILIZATION
• Provider
• Lack of time
• Lack of knowledge
• Lack of a standardized format

• Patient
• Lack of family history knowledge
• Lack of knowledge of importance of the FHH

NEED FOR PROJECT

• Need for improvement recognized by the CDC, NIH and the Surgeon General
• One survey showed that 96 percent of Americans believe that knowing their
family history is important, but only one-third of Americans have tried to
obtain a FHH.2
• Another study found that despite the launch of the Surgeon General’s
campaign, 93% still need “encouragement” to obtain their FHH. 3

STATISTICS

• 5-10% of cancers, a hereditary genetic mutation is the cause. 4
• Colorectal cancer is the third leading cause of death in the United States, fourth
leading cause of death worldwide. 5
• The American Cancer Society estimates the number of colorectal cancer cases in
the United States for 2021 are: 104,270 new cases of colon cancer and 45,230 new
cases of rectal cancer.6
• Evidence reveals that as many as 1 in 3 people who develop colorectal cancer have
other family members who have had it and approximately 5% of people who
develop colorectal cancer have inherited gene mutations that have caused the
cancer.7 These patients may have benefited from early FHH analysis which could
have indicated earlier screening or a referral for genetic counselling

SITE
❖ DLDC/ GI Medical Services

❖ GI Practice
❖ North Shore of Staten Island, NY
❖ Consists: One MD, One NP and 6 office
staff members
❖ Patient screening for family history of
cancer/ diseases- needs improvement

SITE RELATED STATISTICS

• In NYC, more than 1,200 adults die each year from colon cancer. Second
leading cause of cancer death in NYC. In New York State the rate of
developing colon cancer is 39.1 per 100,000 people. 8,9

• There is a population affected by a cancer with potential
genetic predispositions, which may benefit from early
screening at project site.

GI C ANCERS

AIM

The aim of the project was to improve the collection of
the FHH. The influence of patient education and use of
an electronic app was used to determine if these two
factors would improve the collection of the FHH,
possibly resulting in heightened patient preventative
strategies/ actions, such as genetic counseling or earlier/
increased screening practices.

OBJECTIVES

• To expand the patient’s knowledge on the importance of
the FHH
• Investigate if an app was a feasible and accurate tool to
collect the FHH

• Determine if the app would offer the health care provider
patient specific screening recommendations.

BENEFITS OF PROJECT

SHORT TERM BENEFITS

• Decrease patient anxiety of the
unknown
• Encourage the patient to start health
related behaviors
• Decrease potential hospitalizations
and procedures
• Delay disease onset

LONG TERM BENEFITS

• Prevent avoidable death
• Improve the patient’s quality of life
• Reduce prevalence of complications
from genetic diseases and cancers

KURT LEWIN’S
MODEL OF CHANGE
Unfreezing
•

Convincing patients that the
FHH is important and should
be collected. This was done
through patient education.

Movement
•

Patients agree that the FHH
is important and useful and
collect the history through
the app. FamGenix

Refreezing
•

Patients continue to place
importance on the FHH and
educate others on it

•

Patients share their FHH with
other health care providers
and their family members

•

Patients expand upon/ add to
the FHH when indicated

TIMELINE FOR PROJECT

• September 2020: Mailing out of information and request
for patients to participate in the research
• October- November 2020: Collection of data
• December 2020:Analyzation and summarization of data

DESIGN
Hybrid Implementation Effectiveness Trial

Hybrid Type 3 = testing an implementation
intervention (patient education and FamGenix
app) while gathering information on the clinical
intervention and related outcomes.

FUNDING

The project was financed through a grant in the
amount of $3000.00 provided by the PSC/CUNY
Professional Development Funds in the Adjunct and
Continuing Education Teacher Series.

METHODOL OG Y
Staff Education and
Stakeholder Meetings

Recruitment

Enrollment

Meetings 2 weeks prior to start of
project

Convenience Sample 200 + patients
were invited to participate

Aim = 20 patients

Staff Education

Strict Inclusion Criteria

Recruitment through: Flyer and
Personal Invitation

Express interest and then be provided
materials for project

METHODOL OG Y
Participant Instructions

Pre-intervention Survey

Participant Education

1.

Sign informed consent

Returned in office at time of sign up

2.

Complete pre-intervention
survey

Read pamphlet: A Guide to Family
Health History

3.

Read the FHH pamphlet

4.

Collect the FHH data from their
family

5.

Download the FamGenix app

6.

Enter the FHH information and
the appropriate clinician code
into the FamGenix app

SURVEY
Completely
Disagree
I can easily recall the health history
for most of my relatives.
Collecting family health history is
helpful for understanding my own
disease risk.
Collecting family health history is
helpful for understanding my
family’s disease risk.
Family health history collection can
help me reduce risks for heritable
diseases (diseases that run in my
family).
Reporting family health history
could aid in the early detection of
chronic diseases including cancer.
Family health history does not have
the power to predict my personal
health outcomes.

Mostly Disagree

Somewhat
Disagree

Somewhat Agree Mostly Agree

Completely
Agree

FAMGENIX

METHODOL OG Y

FamGenix

Confirmation of
Participant Enrollment

Download FamGenix App

Two weeks prior

Enter Clinician Code

Day Prior

Enter FHH

Review
Prior to follow- up visit healthcare
provider will log in and review data

METHODOL OG Y
Post-Intervention Survey

Discussion and Follow-up

Patient Compensation

Occurred after patient has entered
the data into the FamGenix App.This
was given a paper copy of this at
follow-up visit.

Discussion of results and
recommendation had with pt. at
follow-up visit.

Delivered to participant at their point
of completion.

Referrals made at this time.
One month after referrals are made
then the health care provider will
follow up with pt. to ensure that pt.
followed through with
recommendations.

ANALYSIS

Patient Knowledge

No statistical significance between the means of the pre and post
intervention surveys indicates that patients are already aware of the
importance of the FHH.

Patient Ability

Patient’s accurate and complete data entry using the app demonstrates
that an app/ electronic data entry may be an effective and time efficient
way to gather patient FHH.

Accuracy of the FHH

In regard to improving accurate collection of the FHH, 4 participant’s
data (20%) that were entered into the app improved.This reveals that
even with the awareness of the importance of FHH there is room for
improvement in the collection of the FHH.

Identification of high-risk
patients

Ten percent of the sample being newly identified as high risk for genetic
cancer, demonstrates that electronic use of FHH apps/ programs may
increase identification of patients that may potentially be affected by
genetic cancers/ diseases.

LIMITATIONS

• Small sample size
• One practice
• Homogenous Sample

• Bias
• Patients had to be able to download and use the app

CONCLUSIONS
• Improving the collection of the family health history can increase the
identification of patients at high risk for genetic diseases and cancers of adult
patients in a gastrointestinal practice through the incorporation of a family
health history tool and patient education.
• Collecting an accurate FHH does have the potential to result in earlier detection
of genetically inherited cancers and diseases.
• Health care providers need to be aware of barriers of collecting an accurate
FHH and also take the time to screen patients, but they then also need to know
how to apply the data collected. Providers need to be aware of current
screening guidelines and practices.
• Patients need to make a concentrated effort to collect an accurate family health
history and in turn be prepared to share this information with their health care
provider.

RECOMMENDATIONS

• Vary the Demographic
• Non-specialized medical practice
• Different Collection Tools
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